Search Medicines & Medical Devices

Curated Report Builder

Select medicine rows from results below to preview a paid report. Quote is based on selected items.

Medicine results for DAFRA PHARMA GmbHSwitzerland 42 medicines in Kenya

0 selected

Price column visibility: locked (sign in required)

Page 1 of 3

Reg No.	Product Name	Active Ingredient	Manufacturer	Status
H2016/CTD4273/744	INFLUVAC VACCINE	1. HAEMAGLUTTININ OF: • A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181) • A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN(A/ SWITZERLAND/9715293/2013, NIB-88) • B/PHUKET/3073/2013-LIKE STRAIN (B/PHUKET/3073/2013, WILD TYPE) 2. NEURAMINIDASE	IMPERIAL MANAGED SOLUTIONS EAST AFRICA LTD- MLOLONGO	Registered	Details →
15441	DAFRACLAV 1000 MG TABLETS	AMOXICILLIN CLAVULANIC ACID	ENERGIA PHARMA LIMITED	Registered	Details →
H2006/265 (15442)	DAFRACLAV 228 MG SUSPENSION	AMOXICILLIN CLAVULANIC ACID	ENERGIA PHARMA LIMITED	Registered	Details →
H2006/264 (15443)	DAFRACLAV 457 MG SUSPENSION	AMOXICILLIN CLAVULANIC ACID	ENERGIA PHARMA LIMITED	Registered	Details →
H2006/263 (15440)	DAFRACLAV 625 MG TABLETS	AMOXICILLIN CLAVULANIC ACID	ENERGIA PHARMA LIMITED	Registered	Details →
H2006/264 (15443)/R1	Dafraclav 457 mg suspension	Amoxicillin Clavulanic acid	Dafra Pharma GmbH	Retained	Details →
H2016/CTD2780/986//R1	DUOSKIN CREAM	ISOCONAZOLE NITRATE AND DIFLUCORTOLONE VALERATE	ENERGIA PHARMA LIMITED	Registered	Details →
H2008/19120/737/R1	Co-Arinate FDC adult	Artesunate Sulfamethoxypyrazine Pyrimethamine	Dafra Pharma GmbH	Retained	Details →
H2008/19221/738/R1	Co-Arinate FDC junior	Artesunate Sulfamethoxypyrazine Pyrimethamine	Dafra Pharma GmbH	Retained	Details →
13634	ARTESIANE 20	ARTEMETHER	Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.		Details →
H2016/CTD2854/630	ARTESIANE 300	ARTEMETHER	Dafra Pharma GmbH	Withdrawn Voluntarily by MAH	Details →
H2009/19741/081	ARTESIANE 40	ARTEMETHER	Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.		Details →
H2001/005	SEKROL SYRUP 15 MG	AMBROXOL HCL	ENERGIA PHARMA LIMITED	Registered	Details →
H2001/006	SEKROL SYRUP 30 MG	AMBROXOL HCL	ENERGIA PHARMA LIMITED	Registered	Details →
H2016/CTD2922/173	TERBINOL® SPRAY	TERBINAFINE HYDROCHLORIDE	Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.		Details →
H2000/0335/13368/R1	CETAFOR 1000 MG IV	CEFTRIAXONE	ENERGIA PHARMA LIMITED	Registered	Details →
H2013/21959/096	CETAFOR 500 MG IM	CEFTRIAXONE	Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.		Details →
H2000/0334/13367/R1	CETAFOR 500 MG IV	CEFTRIAXONE	ENERGIA PHARMA LIMITED	Registered	Details →
H2016/CTD2921/172	TERBINOL CREAM	TERBINAFINE HYDROCHLORIDE	ENERGIA PHARMA LIMITED	Registered	Details →
{H2016/CTD2333/322}	MERONIA 1000 IV SOLUTION FOR INJECTION	MEROPENEM TRIHYDRATE.	ENERGIA PHARMA LIMITED	Registered	Details →

1 2 3

Medical Device Matches 8 devices

Showing 8 results.

Device ID	Tradename	Manufacturer	Reg No.	WIPO Basic No.	Status
8780	Access Devices	BD Switzerland Sarl	MD/2022/919	-	VALID	Details →
1840	Alaris Software	CareFusion Switzerland 317 Sarl	MD/2022/1052	-	VALID	Details →
4219	Alarisâ„¢ GP Infusion sets	BD Switzerland Sarl	MD/2022/1054	-	VALID	Details →
1594	Alarisâ„¢ Syringe Pumps	CareFusion Switzerland 317 Sarl	MD/2022/681	-	VALID	Details →
21462	BD PhaSeal Optima Closed System Drug-Transfer…	BD Switzerland Sarl	MD/2026/1311	-	VALID	Details →
8771	EXTENSION SETS	BD Switzerland Sarl	MD/2022/2044	-	VALID	Details →
8790	Extension and Gravity Sets	BD Switzerland Sarl	MD/2022/612	-	VALID	Details →
6871	INFUSION ADMINISTRATION SET FOR GRAVITY	BD Switzerland Sarl	MD/2022/613	-	VALID	Details →

Access Devices

8780 MD/2022/919

BD Switzerland Sarl

Details

Alaris Software

1840 MD/2022/1052

CareFusion Switzerland 317 Sarl

Details

Alarisâ„¢ GP Infusion sets

4219 MD/2022/1054

BD Switzerland Sarl

Details

Alarisâ„¢ Syringe Pumps

1594 MD/2022/681

CareFusion Switzerland 317 Sarl

Details

BD PhaSeal Optima Closed System Drug-Transfer…

21462 MD/2026/1311

BD Switzerland Sarl

Details

EXTENSION SETS

8771 MD/2022/2044

BD Switzerland Sarl

Details

Extension and Gravity Sets

8790 MD/2022/612

BD Switzerland Sarl

Details

INFUSION ADMINISTRATION SET FOR GRAVITY

6871 MD/2022/613

BD Switzerland Sarl

Details

Elsewhere on MedStatus

"DAFRA PHARMA GmbH, Switzerland" also matches these in Kenya.

Manufacturers

Dafra Pharma GMBH

4 products

Search Medicines & Medical Devices

Curated Report Builder

Medicine results for DAFRA PHARMA GmbHSwitzerland 42 medicines in Kenya

INFLUVAC VACCINE

DAFRACLAV 1000 MG TABLETS

DAFRACLAV 228 MG SUSPENSION

DAFRACLAV 457 MG SUSPENSION

DAFRACLAV 625 MG TABLETS

Dafraclav 457 mg suspension

DUOSKIN CREAM

Co-Arinate FDC adult

Co-Arinate FDC junior

ARTESIANE 20

ARTESIANE 300

ARTESIANE 40

SEKROL SYRUP 15 MG

SEKROL SYRUP 30 MG

TERBINOL® SPRAY

CETAFOR 1000 MG IV

CETAFOR 500 MG IM

CETAFOR 500 MG IV

TERBINOL CREAM

MERONIA 1000 IV SOLUTION FOR INJECTION

Medical Device Matches 8 devices

Access Devices

Alaris Software

Alarisâ„¢ GP Infusion sets

Alarisâ„¢ Syringe Pumps

BD PhaSeal Optima Closed System Drug-Transfer…

EXTENSION SETS

Extension and Gravity Sets

INFUSION ADMINISTRATION SET FOR GRAVITY

Elsewhere on MedStatus

Manufacturers